Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma

<p>40 min full dynamic Total-body PET imaging of Patient 8</p>

Сохранить в:

Библиографические подробности
Главный автор:	Xiaojiang Duan (15439264) (author)
Другие авторы:	Lei Xia (15439267) (author), Zhuochen Zhang (15439270) (author), Yanan Ren (15439273) (author), Martin G. Pomper (10938220) (author), Steven P. Rowe (10938217) (author), Xuesong Li (15439276) (author), Nan Li (15276704) (author), Ning Zhang (15439279) (author), Hua Zhu (15439282) (author), Zhi Yang (15439285) (author), Xinan Sheng (15030377) (author), Xing Yang (15439288) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Methods and Technology Biomarkers Imaging biomarkers Clinical Imaging Genitourinary Cancers Bladder cancer Imaging Imaging probes Positron emission tomography (PET) Translational Research
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
по: Xiaojiang Duan (15439264)
Опубликовано: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
по: Xiaojiang Duan (15439264)
Опубликовано: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
по: Xiaojiang Duan (15439264)
Опубликовано: (2025)

Supplementary Figure 1 from <sup>18</sup>F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors
по: Anand Giddabasappa (16494560)
Опубликовано: (2025)

Supplementary Figure 2 from <sup>18</sup>F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors
по: Anand Giddabasappa (16494560)
Опубликовано: (2025)

Supplementary Figure 3 from <sup>18</sup>F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors
по: Anand Giddabasappa (16494560)
Опубликовано: (2025)

Supplementary Figure 4 from <sup>18</sup>F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors
по: Anand Giddabasappa (16494560)
Опубликовано: (2025)

Supplementary Data from Assessment of Tumor Redox Status through (<i>S</i>)-4-(3-[<sup>18</sup>F]fluoropropyl)-L-Glutamic Acid PET Imaging of System x<sub>c</sub><sup>−</sup> Activity
по: Patrick N. McCormick (14937558)
Опубликовано: (2025)

Supplementary Data from Assessment of Tumor Redox Status through (<i>S</i>)-4-(3-[<sup>18</sup>F]fluoropropyl)-L-Glutamic Acid PET Imaging of System x<sub>c</sub><sup>−</sup> Activity
по: Patrick N. McCormick (14937558)
Опубликовано: (2025)

Supplementary Data from Assessment of Tumor Redox Status through (<i>S</i>)-4-(3-[<sup>18</sup>F]fluoropropyl)-L-Glutamic Acid PET Imaging of System x<sub>c</sub><sup>−</sup> Activity
по: Patrick N. McCormick (14937558)
Опубликовано: (2025)

<sup>18</sup>F‑/<sup>68</sup>Ga-Labeled Peptide-Based Probes for PET Imaging of ROR1 Expression
по: Tao Yang (184280)
Опубликовано: (2025)

<sup>18</sup>F‑/<sup>68</sup>Ga-Labeled Peptide-Based Probes for PET Imaging of ROR1 Expression
по: Tao Yang (184280)
Опубликовано: (2025)

From Inhibitors to PET: SAR-Based Development of [<sup>18</sup>F]SK60 for mIDH1 Imaging
по: Sarandeep Kaur (12981271)
Опубликовано: (2025)

FigureS1 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS10 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS2 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS3 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS4 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS5 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS6 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS7 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS8 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

FigureS9 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Supplementary MovieS 1a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Supplementary MovieS1b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Supplementary MovieS1c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Supplementary MovieS1d from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Supplementary MovieS2a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Supplementary MovieS2b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Supplementary MovieS2c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
по: Jonathan Chou (14957015)
Опубликовано: (2025)

Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
по: Noor Jailkhani (16015810)
Опубликовано: (2025)

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
по: Noor Jailkhani (16015810)
Опубликовано: (2025)

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
по: Noor Jailkhani (16015810)
Опубликовано: (2025)

Table S1 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
по: Tongtong Wu (21903016)
Опубликовано: (2025)

Table S2 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
по: Tongtong Wu (21903016)
Опубликовано: (2025)

Table S3 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
по: Tongtong Wu (21903016)
Опубликовано: (2025)

Table S4 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
по: Tongtong Wu (21903016)
Опубликовано: (2025)

Table S5 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
по: Tongtong Wu (21903016)
Опубликовано: (2025)

Table S6 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
по: Tongtong Wu (21903016)
Опубликовано: (2025)

Table S7 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
по: Tongtong Wu (21903016)
Опубликовано: (2025)